92 related articles for article (PubMed ID: 35746495)
1. HPV Vaccination in Women with Cervical Intraepithelial Neoplasia Undergoing Excisional Treatment: Insights into Unsolved Questions.
Henere C; Torné A; Llupià A; Aldea M; Martí C; Glickman A; Saco A; Marimon L; Manzotti C; Rakislova N; Ordi J; Del Pino M
Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746495
[TBL] [Abstract][Full Text] [Related]
2. HPV Vaccination as Adjuvant to Conization in Women with Cervical Intraepithelial Neoplasia: A Study under Real-Life Conditions.
Del Pino M; Martí C; Torras I; Henere C; Munmany M; Marimon L; Saco A; Torné A; Ordi J
Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32456136
[No Abstract] [Full Text] [Related]
3. Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study.
Casajuana-Pérez A; Ramírez-Mena M; Ruipérez-Pacheco E; Gil-Prados I; García-Santos J; Bellón-Del Amo M; Hernández-Aguado JJ; de la Fuente-Valero J; Zapardiel I; Coronado-Martín PJ
Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214747
[No Abstract] [Full Text] [Related]
4. Surgical Treatment of Vulvar HSIL: Adjuvant HPV Vaccine Reduces Recurrent Disease.
Ghelardi A; Marrai R; Bogani G; Sopracordevole F; Bay P; Tonetti A; Lombardi S; Bertacca G; Joura EA
Vaccines (Basel); 2021 Jan; 9(2):. PubMed ID: 33503866
[TBL] [Abstract][Full Text] [Related]
5. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
6. Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain).
Hernandez-Aguado JJ; Sánchez Torres DÁ; Martínez Lamela E; Aguión Gálvez G; Sanz Espinosa E; Pérez Quintanilla A; Martínez-Carrillo DA; Ramírez Mena M; Coronado Martín PJ; Zapardiel I; de la Fuente-Valero J
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335019
[TBL] [Abstract][Full Text] [Related]
7. Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers.
Dehlendorff C; Baandrup L; Kjaer SK
J Natl Cancer Inst; 2021 Jul; 113(7):869-874. PubMed ID: 33377930
[TBL] [Abstract][Full Text] [Related]
8. Effect of HPV Vaccination on Virus Disappearance in Cervical Samples of a Cohort of HPV-Positive Polish Patients.
Pruski D; Millert-Kalińska S; Łagiedo M; Sikora J; Jach R; Przybylski M
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137661
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years.
Hidalgo-Tenorio C; Pasquau J; Omar-Mohamed M; Sampedro A; López-Ruz MA; López Hidalgo J; Ramírez-Taboada J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498165
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer.
Kamolratanakul S; Pitisuttithum P
Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960159
[TBL] [Abstract][Full Text] [Related]
12. Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women.
Aro K; Nieminen P; Louvanto K; Jakobsson M; Virtanen S; Lehtinen M; Dillner J; Kalliala I
Gynecol Oncol; 2019 Aug; 154(2):354-359. PubMed ID: 31176553
[TBL] [Abstract][Full Text] [Related]
13. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study.
Tozawa-Ono A; Kamada M; Teramoto K; Hareyama H; Kodama S; Kasai T; Iwanari O; Koizumi T; Ozawa N; Suzuki M; Kinoshita K
Hum Vaccin Immunother; 2021 Apr; 17(4):950-954. PubMed ID: 33121340
[TBL] [Abstract][Full Text] [Related]
15. The Human Papillomavirus Infection Characteristics for Patients with Cervical Intraepithelial Neoplasia in Yunnan, China: A Sampling Survey Analysis.
Zhi HF; Yang LF; Ge J; Yang XT
Infect Drug Resist; 2022; 15():2843-2851. PubMed ID: 35673547
[TBL] [Abstract][Full Text] [Related]
16. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
Gertig DM; Brotherton JM; Budd AC; Drennan K; Chappell G; Saville AM
BMC Med; 2013 Oct; 11():227. PubMed ID: 24148310
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of high-risk human papillomavirus types in Mexican women with cervical intraepithelial neoplasia and invasive carcinoma.
López-Revilla R; Martínez-Contreras LA; Sánchez-Garza M
Infect Agent Cancer; 2008 Feb; 3():3. PubMed ID: 18307798
[TBL] [Abstract][Full Text] [Related]
18. Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study.
Tabrizi SN; Brotherton JM; Kaldor JM; Skinner SR; Liu B; Bateson D; McNamee K; Garefalakis M; Phillips S; Cummins E; Malloy M; Garland SM
Lancet Infect Dis; 2014 Oct; 14(10):958-66. PubMed ID: 25107680
[TBL] [Abstract][Full Text] [Related]
19. Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Trial Protocol.
Stankiewicz Karita HC; Hauge K; Magaret A; Mao C; Schouten J; Grieco V; Xi LF; Galloway DA; Madeleine MM; Wald A
JAMA Netw Open; 2019 Apr; 2(4):e190819. PubMed ID: 30977845
[TBL] [Abstract][Full Text] [Related]
20. Beneficial Effects of Human Papillomavirus Vaccine for Prevention of Cervical Abnormalities in Miyagi, Japan.
Ozawa N; Ito K; Tase T; Metoki H; Yaegashi N
Tohoku J Exp Med; 2016 Oct; 240(2):147-151. PubMed ID: 27746423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
